JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1991; 17:1537-1544
© 1991 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kushwaha, S.
Right arrow Articles by Yacoub, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kushwaha, S.
Right arrow Articles by Yacoub, M.

Substance P for evaluation of coronary endothelial function after cardiac transplantation

SS Kushwaha, DC Crossman, M Bustami, GJ Davies, AG Mitchell, A Maseri, and MH Yacoub

Department of Cardiology, Harefield Hospital, Middlesex, England.

The endothelium-dependent vasodilator substance P dilates normal and diseased coronary vessels in humans in vivo and produces a maximal response similar to that seen with intracoronary isosorbide dinitrate. Twelve cardiac transplant recipients underwent intracoronary infusion of substance P after routine annual investigations. All patients were well, with no evidence of rejection and with angiographically normal coronary arteries. Substance P was infused at 2 ml/min for 2 min into the coronary artery, starting at a dose of 1.4 pmol/min and increasing by doubling increments, and followed by isosorbide dinitrate (1 mg/min) infused over 2 min. Coronary artery diameter was measured in 23 vessel segments from 12 transplant recipients. The following doses were infused: saline solution (1 ml/min), substance P (0.7 [three patients], 1.4, 2.8, 5.6, 11.2, 22.4 pmol/min) and isosorbide dinitrate (1 mg/min). The mean percent increase in diameter (+/- SEM) in response to increasing doses of substance P was as follows: 0, 6.5 +/- 2.9%, 10.9 +/- 2.9%, 12.1 +/- 2.9%, 16.5 +/- 2.6%, 19.2 +/- 3.1% and 25.8 +/- 2.2%, respectively. Half maximal dilation was produced with 1.4 to 2.8 pmol/min of substance P; the maximal response (mean percent diameter change) was 22 +/- 2.5%. This was not significantly different from that achieved with isosorbide dinitrate. It is concluded that coronary endothelial function as assessed by response to substance P is preserved in cardiac transplant recipients with angiographically normal coronary arteries. Substance P may be a suitable agent for testing endothelial function in these patients.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
G. Berkenboom, V. Crasset, and P. Unger
Coronary endothelial dysfunction in the early months after heart transplantation
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 969 - 969.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Aptecar, E. Teiger, P. Dupouy, C. Benvenuti, M. J. Kern, J. Woscoboinik, S. Sediame, J. M. Pernes, A. Castaigne, D. Loisance, et al.
Effects of bradykinin on coronary blood flow and vasomotion in transplant patients
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1607 - 1615.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, C Tentolouris, T Crake, C Stefanadis, P Toutouzas, and G Davies
Evidence of partially preserved endothelial dilator function in diseased coronary arteries
Heart, October 1, 1999; 82(4): 471 - 476.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Bartunek, A. M. Shah, M. Vanderheyden, and W. J. Paulus
Dobutamine Enhances Cardiodepressant Effects of Receptor-Mediated Coronary Endothelial Stimulation
Circulation, January 7, 1997; 95(1): 90 - 96.
[Abstract] [Full Text]


Home page
CirculationHome page
A. A. Quyyumi, D. Mulcahy, N. P. Andrews, S. Husain, J. A. Panza, and R. O. Cannon III
Coronary Vascular Nitric Oxide Activity in Hypertension and Hypercholesterolemia: Comparison of Acetylcholine and Substance P
Circulation, January 7, 1997; 95(1): 104 - 110.
[Abstract] [Full Text]


Home page
CirculationHome page
E. Aptecar, P. Dupouy, C. Benvenuti, J.-P. Mazzucotelli, E. Teiger, H. Geschwind, A. Castaigne, D. Loisance, and J.-L. Dubois-Rande
Sympathetic Stimulation Overrides Flow-Mediated Endothelium-Dependent Epicardial Coronary Vasodilation in Transplant Patients
Circulation, November 15, 1996; 94(10): 2542 - 2550.
[Abstract] [Full Text]


Home page
CirculationHome page
E. A. Caracciolo, T. L. Wolford, R. D. Underwood, T. J. Donohue, R. G. Bach, L. W. Miller, and M. J. Kern
Influence of Intimal Thickening on Coronary Blood Flow Responses in Orthotopic Heart Transplant Recipients : A Combined Intravascular Doppler and Ultrasound Imaging Study
Circulation, November 1, 1995; 92(9): 182 - 190.
[Abstract] [Full Text]


Home page
CirculationHome page
L. H. Manciet, K. A. Fox, J. G. Copeland, D. S. Wilson, P. R. Reimer, and P. F. McDonagh
Left Ventricular Function After Extended Hypothermic Preservation of the Heart Is Dependent on Functional Coronary Capillarity
Circulation, November 1, 1995; 92(9): 372 - 380.
[Abstract] [Full Text]


Home page
CirculationHome page
W. J. Paulus, P. J. Vantrimpont, and A. M. Shah
Paracrine Coronary Endothelial Control of Left Ventricular Function in Humans
Circulation, October 15, 1995; 92(8): 2119 - 2126.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1991 by the American College of Cardiology Foundation.